Explore the diverse career pathways available within one of Australia's largest public research organisations.
Sydney
Showing 81 - 100 of 293 results
Explore the diverse career pathways available within one of Australia's largest public research organisations.
Sydney
Fossils go nuclear
Using light to understand disease
Development of radiotracers
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
ANSTO collaborator awarded Investigator Grant to explore bush medicine in contemporary healthcare
Southern Cross researcher Dr Alana Gall, who recently became an ANSTO research Fellow, has been awarded more than $640,000 to lead a research program focused on First Peoples' Cultural Medicines (also called bush medicine) in Australian healthcare.
Studying stonefish venom may help combat transplant rejection
New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
The Australian Synchrotron
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
Science Meets Business: Innovation series
The ANSTO Innovation Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.
Australia’s Nuclear Age Celebrates 70 Years
Education Manager
Dr Bridget Murphy has a background in biological science research and science education at secondary and tertiary levels.
New flow chemistry capability to enhance NDF production capacity
Nuclear techniques reveal membrane interaction of novel therapeutic option to combat superbugs
ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.
Understanding radiation damage at the atomic scale
Celebrating crystallography - New video
Potential immunotherapy strategy for HIV
A “super” receptor that helps kill HIV infected cells identified.
Senior Principal Research and Neutron Scattering Instrument Scientist
Role at ANSTO
- Leader, Energy Materials Research Project
Breaking the mould: Leadership announcement
Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science
Nuclear techniques help unlock structure
Research on a rare type of superconducting intermetallic alloy